U.S. stocks closed mostly lower Thursday as the Federal Reserve kept interest rates unchanged in an unanimous decision and signaled that it would continue to tighten monetary policy at a gradual pace.
Nikkei surrenders gain of more than 1% to end lower after back-and-forth session
Investors watching election aftermath for eventual potential changes on Iran, energy regulation
The midterm elections delivered a split decision on Congress, as expected, with results still trickling in early Wednesday.
Disney will divest its interests in the History, H2, Crime & Investigation, Blaze and Lifetime channels in Europe
Adding even $5 to your savings each month adds up in a big way
Recent study calls it a “coming storm of broke elderly”
Nikkei rises despite SoftBank’s fall; stocks in China and Hong Kong slip
Company poised to end session with a market cap below $1 trillion
Apple falls in late trading despite earnings beat, thanks to forecast that appears cautious for several reasons
Despite cash infusion, Windtree still faces money running out within a year
Pain medicine biotech Latigo taps CRO founder for CMO role
Johnson & Johnson to buy heart failure implant company V-Wave for up to $1.7B
Talus Bio tacks on $11M to target hard-to-reach transcription factors
Pathalys raises $105M series B to prepare Japan-approved kidney disease drug for FDA
Denmark’s Adcendo signs $1B biobuck deal for Multitude’s anti-TF ADC
Merck & Co. bags one Kelun ADC for $37.5M, boots out another asset as pipeline tinkering continues
Avantor sells clinical services unit to private equity firm for $650M
‘We’re pretty prolific’: Lilly Catalyze360 looks to connect with emerging biotechs across ‘all areas’
FDA clears its first at-home blood test for syphilis
